| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,192,100 | 3,796,600 | 3,647,100 | 4,592,900 | | Cost of Revenue | 3,485,500 | 3,101,200 | 2,977,300 | 3,639,200 | | | Gross Profit | 706,600 | 695,400 | 669,800 | 953,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 664,600 | 673,300 | 664,300 | 804,800 | | Non Recurring | 61,000 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (19,000) | 22,100 | 5,500 | 148,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,800) | 3,100 | 1,200 | (10,300) | | Earnings Before Interest And Taxes | (26,800) | 25,200 | 6,700 | 138,600 | | Interest Expense | 21,500 | 13,900 | 13,100 | 2,000 | | Income Before Tax | (48,300) | 11,300 | (6,400) | 136,600 | | Income Tax Expense | 2,100 | (8,000) | (8,700) | 57,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (50,400) | 19,300 | 2,300 | 79,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (50,400) | 19,300 | 2,300 | 79,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($50,400) | $19,300 | $2,300 | $79,200 |
|
0.78% Nasdaq 
Income Statement
